Hitesh Kapadia, D.D.S.

• Craniofacial Center, Department of Dentistry
• Seattle Children? Hospital
• Seattle, Washington

However hiv infection lymphadenopathy 5mg medex buy with amex, since the vagina is normally lined by non-keratinising squamous Cervical Cancer Cervical cancer develops from the cervix antiviral vegetables medex 5mg buy. Due to the presence of various epithelial types in cervix hiv infection photos buy medex on line amex, several malignant growths can occur in cervix hiv infection epidemiology pathogenesis treatment and prevention generic medex 1mg without a prescription, including squamous cell carcinoma antiviral used to treat herpes purchase medex 5mg on-line, adenocarcinoma and sarcoma. Nevertheless, squamous cell carcinoma is the most common type of carcinoma affecting the transformation zone. This cancer may result in abnormal bleeding, such as irregular vaginal bleeding, postcoital bleeding, bleeding in between periods, etc. Papanicolaou (Pap) test is a screening test, which helps in detecting cervical abnormalities at an early stage. Some risk factors for cervical cancer are young age at the time of first sexual intercourse, having multiple sexual partners, history of smoking cigarettes and having disorders of immune system. A typical myoma is a pale, firm, rubbery, well-circumscribed mass distinct from neighbouring tissues and has a whorled appearance due to presence of interlacing fibres of myometrial muscle, surrounded by a connective tissue capsule. Of the different types of fibroids, the most common are intramural or interstitial fibroids (which are present within the uterine myometrium), followed by submucosal fibroids (which grow beneath the uterine endometrial lining) and subserosal fibroids (which grow beneath the uterine serosa). Another lesion, which may be commonly present within the myometrium, is adenomyosis. It is characterised by the presence of nests or nodules of endometrium within the myometrial tissues (usually >2. It is associated with myometrial hypertrophy, which may be either diffuse, or localised (adenomyoma). Uterus Endometrium Endometrial cancer develops from the lining of the uterus, also known as the endometrium. It is the most common gynaecologic cancer and the fourth most common cancer amongst women. The structure of uterine endometrium varies throughout the menstrual cycle under the influence of hormones such as oestrogen and progesterone. In the first half of menstrual cycle (also known as the follicular phase), oestrogens cause proliferation of the endometrial endothelium. In the second half of menstrual cycle, secretory changes occur in the uterine endometrium under the influence of progesterone. As would be expected, the commonest malignancy occurring at this site would be endometrial adenocarcinoma. The probable precursor lesion for endometrial adenocarcinoma is endometrial hyperplasia, which may occur in the presence of high oestrogen states. The risk is greatest in cases of atypical endometrial hyperplasia, which is characterised by both architectural and cytological abnormalities. Approximately 1 in every 50 women is likely to get affected with the endometrial cancer. The most common symptom associated with endometrial cancer is abnormal uterine bleeding. Endometrial cancer usually affects women after menopause, commonly in the age group of 50­65 years. Uterine leiomyomas (uterine myomas, fibromyomas or fibroids) are well-circumscribed benign. Ovarian cancer usually does not cause symptoms, until it is large or is in an advanced stage. Hence, cancer of the ovaries has the worst prognosis in comparison to any other type of gynaecologic cancer. Some of the risk factors for ovarian cancer include old age, nulliparity, having the first child late in life, early menarche, late menopause and family history of cancer of the uterus, breast or large intestine. Nearly 80% of the cancers are epithelial cell cancers, which begin from the surface epithelium of the ovaries. Ovarian carcinomas may differentiate along various pathways thereby resulting in the development of serous, mucinous or endometrioid adenocarcinomas. Other types of ovarian cancers include the germ cell tumours or the stromal cell tumours. Besides, a group of epithelial tumours of intermediate malignancy, also known as borderline tumours may sometimes occur. Sex cord stromal tumours represent neoplasms of specialised stromal cells such as granulosa cells, sertoli cells, theca cells, leydig cells or specialised fibroblasts. The majority of germ cell tumours are benign cystic teratomas, also known as dermoids. Dysgerminoma is another type of germ cell tumour of the ovary which is usually malignant in nature. The ovarian cancer is one of the most aggressive types of cancers, which can spread directly to the surrounding tissues and through the lymphatic system to other parts of the pelvis and abdomen. It can also spread through the bloodstream to the distant body organs, mainly the liver and lungs. Many women with ovarian cancer may not have any symptoms, until the cancer is in an advanced stage. Moreover, if the symptoms do appear, they may be vague such as lower abdomen discomfort, indigestion, bloating, loss of appetite, backache, etc. Inevitable abortion: the process of abortion has progressed to a stage from where continuation of pregnancy is impossible. T Incomplete abortion: In this type of abortion, products of conception have not been fully expelled out of the uterine cavity and can be felt through the cervical os. T Complete abortion: There is expulsion of products of conception en masse, following which there is subsistence of pain or bleeding. On per vaginal examination, the cervical os is closed and uterus is smaller than the period of amenorrhea. T Missed abortion: the foetus is dead and gets retained inside the uterine cavity. T Aetiopathogenesis Pathological examination of the aborted products of conception may help in identifying the underlying pathology for miscarriage. Pathological examination has demonstrated that a common mechanism for first trimester miscarriage is defective trophoblastic invasion of the decidual and uterine vasculature. Although the actual cause of the miscarriage is frequently unclear, the most common reasons include the following: T Genetic factors: Chromosomal abnormalities are probably the most common underlying cause for first and early second trimester miscarriages. These include chromosomal anomalies such as trisomy, polyploidy, monosomy, structural chromosomal aberrations, etc. T Endocrine and metabolic disorders: Endocrine disorders, such as luteal phase defects, thyroid anomalies, diabetes mellitus, etc. Ascending infection of the genital tract with either localised inflammation in the region of cervical os or chorioamnionitis is the most common cause for late second-trimester spontaneous miscarriage. T Immunological disorders: Autoimmune and alloimmune disorders including antiphospholipid syndrome are usually responsible for causing second trimester miscarriage. T Other factors: these may include emotional factors or factors causing stress, certain drugs, caffeine, alcohol, tobacco, cocaine, etc. Maternal exposure to external agents such as drugs or radiation could be another cause for first-trimester miscarriage. Gynaecological Abnormalities pathology of Miscarriage A miscarriage (also known as spontaneous abortion) is any pregnancy, which undergoes spontaneous termination before reaching the period of viability (24 weeks). Different types of miscarriages are as follows: T Threatened abortion: the process of abortion has started, but has not progressed towards completion. This may be the probable diagnosis in an individual with primary amenorrhea and no apparent vagina. The cause of this syndrome is unknown and is probably related to the mutations in the gene for anti-Müllerian hormones or the gene for anti-Müllerian hormone receptor. Other anomalies including the renal tract anomalies such as ectopic kidney, renal agenesis, horseshoe kidney and abnormal collecting ducts are frequently present. Extirpation of the Müllerian remnants, if any present, is not required unless they are causing some problems such as fibroid growth, hematometra, endometriosis, etc. Initially, the dilatation is begun in posterior direction and then after 2 weeks, it is changed to upward direction in the line of vaginal axis. By utilising increasingly larger sized dilators, a functional vagina can be created within a period of several months. It is important for the gynaecologist to provide adequate reassurance and support in these cases. Having regular sexual intercourse helps in maintaining the patency of newly created artificial vaginal orifice. Chemical mediators concerned in production of an inflammatory response include which of the following Wound healing by secondary intention takes place in which of the following circumstances Which obstetric complication has an increased prevalence in women with bicornuate uterus Within what timeframe from injury do macrophages replace neutrophils in case of cutaneous wound healing Which of the following vulval skin disorders is associated with the highest risk of malignancy Which of the following paraneoplastic syndromes is correctly paired with a recognized causal malignancy A 65-years-old woman presented to the gP with the complaints of abdominal distension, reduced appetite and shortness of breath. Which of the following statement is correct regarding the congenital absence of the uterus The bacterium having peptidoglycan in its cell wall is able to take up Gram stain and is therefore considered as Gram positive. On the other hand, bacterium not capable of taking the Gram stain is classified as Gram negative. Besides Gram staining, bacteria can also be classified based on their appearance Table 6. Obligate anaerobes are organisms that live and thrive in the absence of oxygen; such organisms may die in the presence of oxygen. On the other hand, facultative anaerobes are those organisms which are able to alter their function depending on the presence or absence of oxygen. Common forms of bacteria Genus name Streptococcus (-haemolytic) Species Streptococcus pneumoniae S. The most important amongst them is Streptococcus pyogenes causing pyogenic infections, with a characteristic tendency to spread, as opposed to staphylococcal lesions, which are typically localised. In addition, it is also responsible for causing the non-suppurative lesions, acute rheumatic fever and glomerulonephritis. Streptococcus pyogenes produces several exotoxins and enzymes, which contribute to its virulence. Besides these, the M protein (protein antigen present in its cell wall) also acts as a virulence factor by inhibiting phagocytosis. These include infections such as sore throat, streptococcal pharyngitis, scarlet fever, suppurative complications. Pharyngeal carriage rates vary with geographical location, season of the year and age group. Amongst school-aged children, rates of 15­20% have been reported; the carriage rate among adults is considerably lower. Skin and Soft Tissue Infections Streptococcus pyogenes causes a variety of suppurative infections of the skin, including infection of wounds or burns, with a predilection to produce lymphangitis and cellulitis. The two typical streptococcal skin infections are erysipelas (infection involving the superficial lymphatics) and impetigo. Group A streptococci causing impetigo are frequently nephritogenic that leads to acute glomerulonephritis. The main causes leading to acute glomerulonephritis in children in the tropics are impetigo (pyoderma) and streptococcal infection of scabies lesions. Streptococcal Infection Acute diseases associated with Streptococcus pyogenes occur chiefly in the respiratory tract, bloodstream, or the skin. Two post-streptococcal sequelae (rheumatic fever following respiratory infection and glomerulonephritis following respiratory or skin infection) may occur in 1­3% of untreated infections. Group b -haemolytic Streptococcus Also known as Streptococcus agalactiae, this is a common commensal organism in the gastrointestinal tract and normal vaginal flora. As a result of its vaginal carriage, there is a risk of transmission of this organism to the foetus. This is associated with the potential to cause neonatal sepsis following the rupture of membranes. It is much more likely to affect premature babies and is particularly seen after premature rupture of membranes. It can result in complications such as: T Meningitis and neurological sequelae: the commonest aetiology for meningitis in the newborn babies is group B Streptococci, which may be acquired during or after delivery. Even those who survive may suffer from problems such as mental retardation, speech problems, visual impairment and neural deafness (rather than conductive deafness). Vancomycin-resistant enterococci Enterococci were initially classified as enteric Grampositive cocci and later classified as group D streptococci based on the Lancefield serological typing system. However, in the 1980s, enterococci were removed from the genus Streptococcus and placed in their own genus, Enterococcus. These bacteria have been recognised as an important cause of endocarditis and an important cause of nosocomial infection. Vancomycin binds to D-ala-D-ala but the resistant enterococci have D-ala-D-lac or D-ala terminating precursors. High-dose ampicillin is the treatment of choice only if the minimal inhibitory concentration of ampicillin is not too high. So it is not considered worthwhile to screen every mother or to provide antenatal treatment. There is growing evidence that the use of intrapartum antibiotics may prove to be effective. Staphylococcus aureus Staphylococci are Gram-positive cocci, non-motile bacteria that occur in grape-like clusters. Methicillin was the first compound developed to combat resistance due to penicillinase (beta lactamase) production by staphylococci. Species of staphylococci are classified by the coagulase test into two groups: the coagulase-positive. They are universally present and are the most common cause of localised suppurative lesions in human beings. Staphylococci produce several toxins and enzymes which are responsible for its virulence. Mycobacterium Tuberculosis Mycobacteria are aerobic, rod-shaped, Gram-positive, non-motile, non-capsulated and non-sporing, slow growing bacteria. Deep Infections these include: osteomyelitis, periostitis, tonsillitis, pharyngitis, sinusitis, bronchopneumonia, empyema, · · Tubercle bacilli ­ Human-M.

It has a positive inotropic effect (an increase in the force of contraction) hiv infection due to blood transfusion cheap medex 1mg buy, a negative chronotropic effect (a decrease in the heart rate) antiviral drip 1mg medex for sale, and a negative dromotropic effect (a decrease in conduction velocity) hiv symptoms five years after infection buy cheapest medex. Among the various inotropic drugs antiviral state purchase 1 mg medex with visa, digoxin is unique in its ability to strengthen cardiac contraction while decreasing heart rate jurkat hiv infection cheap 1 mg medex fast delivery. Moreover, digoxin increases parasym pathetic tone while reducing sympathetic tone, and this may partly account for its beneficial effects. When the sodium pump is inhibited, the concentration of intracellular sodium is increased, thereby increasing the activity of the sodium calcium exchanger and causing more calcium to enter the cardiac myocyte. The increase in cytoplasmic calcium stimulates the release of additional calcium from the sarcoplasmic reticulum and increases the rate of myofibril shortening (muscle contraction), and the peak systolic muscle tension. The stroke volume is the amount of blood pumped by the ventricle during each systole, and the cardiac output is the amount of blood ejected from either ventricle of the heart per minute. In patients with heart failure, the reduction in sympathetic tone is caused partly by the withdrawal of reflex sympathetic stimulation secondary to the improved cardiac output produced by digoxin. The high sodium concentration increases the activity of the sodiumcalcium exchanger (Ex), thereby causing more calcium to enter or remain inside the cardiac myocyte. Calcium activates muscle fiber shortening and increases cardiac contractility, which in turn increases stroke volume at any given fiber length (preload). The positively inotropic drugs increase stroke volume at any given fiber length and thereby decrease venous pressure and preload. These abnormal depo larizations occur during or immediately after normal cardiac repolarization and lead to extrasystoles (premature or coupled beats) and tachycardia (rapid beating of the heart). The afterdepolarizations appear to be caused by excessive calcium influx into cardiac cells, and they are more likely to occur after higher doses of digoxin have been given. The most common adverse effects of digoxin are gastrointestinal, cardiac, and neurologic reac tions. These reactions are often associated with elevated serum concentrations and may forewarn of more serious toxicity. Hypokalemia can precipitate arrhythmias in patients receiv ing digoxin, and the serum potassium level should be deter mined immediately if arrhythmias occur in these patients. The neurologic effects of digoxin toxicity are usually caused by excessive plasma levels of the drug, and include blurred vision and yellow, green, or blue chromatopsia (a condition in which objects appear unnaturally colored). Because digoxin has some estrogenic activity, it occasion ally causes gynecomastia (excessive growth of male mammary glands). Because antacids and cholestyramine can reduce the absorption of digoxin and decrease its therapeutic effects, their administration should be separated from the administration of digoxin by at least 2 hours. Diltiazem, quinidine, and verapamil reduce digoxin clearance and increase serum digoxin levels, contributing to digitalis toxic ity. When digoxin is used concurrently with these drugs, only 50% of the usual dose of digoxin should be given, and serum digoxin levels should be monitored. Loopacting and thiazide diuretics can cause hypokalemia and precipitate digitalis toxicity, because the reduced serum potassium con centration increases digitalis binding to the sodium pump. Digitalis glycosides have been used to treat heart failure for centuries, but their benefits have been uncertain whereas their toxicity has been substantial. The improvement produced by digoxin in patients with systolic heart failure probably results from a combination of a modest inotropic effect and attenuation of the neuroendocrine con sequences of heart failure such as increased heart rate, vaso constriction, and cardiac afterload. Digoxin is generally not used to treat diastolic heart failure because contractility is usually not impaired in this disorder. Clinical trials have shown that although digoxin does not prolong survival, it reduces symptoms and the need for hos pitalization and improves quality of life of patients with heart failure. Moreover, patients who have been withdrawn from digoxin have experienced a worsening of heart failure. Hence, digitalis will probably continue to have a role in treating patients with heart failure in combination with angiotensin inhibitors, diuretics, blockers, and aldosterone antagonists. The most certain indication for digoxin appears to be the treatment of patients with both heart failure and atrial fibrillation. In these patients, the ventricular rate is often rapid and irregular, causing palpitations and reducing cardiac output. Digoxin causes an increase in parasympathetic (vagal) tone and a decrease in sympathetic tone. Toxic concentrations of digoxin may evoke afterdepolarizations throughout the heart and thereby cause extrasystoles and tachycardia. Digoxin Immune Fab An antidote for severe digoxin toxicity is available in the form of digoxin immune Fab. It is made from immuno globulin fragments taken from sheep previously immunized with a digoxin derivative. This antibody preparation is administered intravenously and can rapidly reverse digoxin toxicity by binding to digoxin. Dobutamine Dobutamine is the adrenoceptor agonist most frequently used in treating heart failure, partly because it selectively stimulates cardiac contractility and usually causes less tachy cardia than other agonists. The drug is administered by continuous intravenous infusion in the shortterm management of acute heart failure and cardiogenic shock. Symptomatic improvement has been documented in patients with heart failure receiving a continuous infusion of dobutamine for 3 to 5 days, and some patients may benefit from dobutamine administration for up to 30 days. However, there is no evi dence that such treatments improve survival, and high doses may increase mortality. For this reason, many authorities believe dobutamine and other intravenous inotropes should be limited to the shortterm management of patients with severe heart failure. The properties and effects of dobutamine are summarized in Tables 121, 122, and 123 and are described in greater detail in Chapter 8. Milrinone is occasionally used in treating acute heart failure and other conditions requiring myocardial stimulation. Milrinone is used for the shortterm management of heart failure in patients who are not responsive to other drugs. It has also been used for inotropic support of infants and children awaiting cardiac transplantation and for other conditions requiring myocardial stimulation. Intravenous administration of milrinone can provide both hemodynamic and symptomatic improvement in persons with advanced heart failure. However, longterm use can cause thrombocy topenia and ventricular arrhythmias and is associated with increased mortality in patients with severe heart failure (Table 124). Despite these limitations, infants awaiting cardiac transplantation have received the drug for up to 6 months without serious adverse effects. Vasodilators are useful in the treatment of heart failure because of their ability to reduce venous and arterial pressure. The reduction in venous pressure decreases edema, whereas the dilation of arteries reduces cardiac afterload and increases cardiac output. In addition, the angiotensin inhibitors slow or reverse cardiac remodeling, which may be responsible for their beneficial effect on the survival of patients with heart failure. Chapter 12 y Drugs for Heart Failure dilatation, wall thinning, and expansion of the infarct zone in these patients. The combined use of these two drugs reduces cardiac preload and afterload, leading to reduced venous pressure and edema and to increased cardiac output, respectively. Hence, the effects of isosorbide dinitrate plus hydralazine are similar to those produced by the angiotensin inhibitors. It was found that this drug combination decreased mortality more than placebo but less than enalapril. For this reason, the hydralazineisosorbide dinitrate combination is sometimes used to treat patients with heart failure who cannot tolerate an angiotensin inhibitor. The AfricanAmerican Heart Failure Trial provided further evidence of the beneficial effects of hydrala zine plus isosorbide dinitrate on the survival of black patients with heart failure. It is approved for the treatment of patients with acutely decompensated heart failure who have shortness of breath (dyspnea) at rest or with minimal activity. Clinical trials show that nesiritide reduced pulmonary capillary wedge pressure, a clinical measure of venous pressure and cardiac preload, and thereby decreased vascular congestion and dyspnea in decompensated patients with heart failure. The most common adverse effect of nesiritide is hypotension, although most cases were not symptomatic. Because nesiritide is a peptide drug, it must be given intravenously, and it is primarily eliminated by Once contraindicated in heart failure because of their negative inotropic effect, the adrenoceptor antagonists (blockers) have emerged as one of the newer treatments for this cardiac condition. This paradigm shift resulted from advances in the understanding of the role of the sympathetic nervous system in cardiac remodeling and the progression of heart failure. Excessive sympathetic nervous system activity contributes to cardiac remodeling in several ways. Sympathetic acti vation of cardiac receptors produces tachycardia and increased oxygen demand, thereby increasing infarct size and the propensity for cardiac remodeling in persons with myo cardial infarction. Sympathetic activation also increases acti vation of the reninangiotensinaldosterone system, whose role in cardiac remodeling was described earlier. In addition, chronic stimulation of cardiac receptors leads to both myocyte hypertrophy and apoptosis in a manner that con tributes to cardiac dilatation and ventricular wall thinning. Finally, activation of the sympathetic system increases pro duction of cardiac cytokines, including tumor necrosis factor and interleukins. These cytokines also induce myocyte hypertrophy and apoptosis and produce alterations in the intracellular matrix that contribute to fibrosis and ventricular wall stiffness. The benefits of therapy with blockers are caused by the ability of these drugs to reduce excessive sympathetic stimu lation of the heart and circulation in patients with heart failure. Several clinical trials have shown that some blockers, particularly carvedilol, metoprolol, and bisoprolol, benefit patients with mild to severe heart failure caused by left ventricular systolic dysfunction. Much of the attention concerning blocker therapy in heart failure has been focused on carvedilol. Carvedilol is a thirdgeneration 1 and 2blocker that also produces vasodilation via 1receptor blockade. In addition, carve dilol and its metabolites have antioxidant properties (described in Chapter 9), and it also exhibits antiinflamma tory and antiapoptotic properties that can contribute to its beneficial effects in heart failure. For these reasons, carve dilol has been called a multiple-action neuroendocrine antagonist. In several clinical trials, carvedilol has been found to increase left ventricular ejection fraction, improve symp toms, and slow disease progression. These studies show that carvedilol reduces both hospitalization and mortality in persons with heart failure when it is added to a standard treatment regimen. Patients should be monitored for the adverse effects of carvedilol, which include bradycardia, worsening heart failure, and dizziness or lightheadedness caused by vasodi lation and decreased blood pressure. Metoprolol and bisoprolol have also been shown to produce beneficial effects in patients with heart failure. Some studies, however, suggest that these drugs are not as beneficial as carvedilol in some patients with heart failure. The pharmacologic properties of diuretics are described in greater detail in Chapter 13. This study has been criticized with respect to whether the doses of the blockers used in the study produced the same degree of blockade. The initiation of blocker therapy in patients with heart failure requires careful attention to dosage titration. Because the beneficial effects of blockers in heart failure have a delayed onset of action and because potential adverse cardiac effects can occur immediately, patients are started on low doses of a blocker and the dose is then gradually titrated upward every 2 to 3 weeks until the target dose is achieved over a period of several months. Patients should be moni tored regularly during the titration period and informed that blockers can lead to increased symptoms for 4 to 10 weeks before any improvement is noted. Spironolactone and eplerenone are mineralocorticoid receptor antagonists that compete with aldosterone for the mineralocorticoid receptor in renal tubules and other tissues. These drugs act on the kidneys to increase sodium excretion, decrease potassium excretion, and exert a moderate diuretic effect. For this reason, spironolactone is classified as a potassiumsparing diuretic; its pharmacologic properties and use are described in Chapter 13. This benefit has been attributed to the prevention of the adverse effects of excessive aldosterone levels on the heart and to an elevation of the serum potas sium level. The survival benefits of these drugs were in addition to those provided by angiotensin inhibitors and blockers. The increased use of these drugs in elderly patients who may have renal insufficiency was initially asso ciated with about a 100% increase in the incidence of hospitalization and death caused by hyperkalemia. Aldosterone produces endocrine side effects resulting from its binding to androgen and progesterone receptors and leading to gynecomastia and impotence in some male patients. Eplerenone produces fewer endocrine side effects than spironolactone (1% versus 10% in clinical trials). Eplerenone is much more expensive, however, and it seems reasonable to begin with spironolactone and switch to eplerenone if endocrine side effects develop. Acute heart failure may require hospitalization and the administration of intravenous vasodilators (such as nitrates and nesiritide), diuretics, inotropic agents, and oxygen. Once stabilized, patients can often be managed with oral medica tions, dietary restrictions, and exercise guidelines (Box 121). Although bed rest may relieve symptoms of heart failure during the early course of therapy, many patients benefit from an incremental exercise program after their condition has improved. The management of chronic heart failure depends on the underlying cause, the degree of cardiac dysfunction, and the particular signs and symptoms exhibited by the patient. On physicalexamination,herpulseis85beats/minandregular, her respiration rate is 25/min, and her blood pressure is 138/84mmHg. Long-term management will include lisinopril, gradually increasing doses of carvedilol, andsimvastatin. Despiterecent advances in the treatment of heart failure, morbidity and mortalityremainhigh. However, they must be used carefully to avoid dehydration, hyponatremia, and hypokalemia. Hypokalemia increases the risk of digoxin toxicity, and patients with heart failure should be closely monitored for this condition. Thiazide diuretics can be used when a lesser degree of diure sis is required in the treatment of heart failure, and they can Chapter 12 y Drugs for Heart Failure continues to have a high mortality rate.

Digitalis glycosides and other cardiac stimulants can indirectly cause diuresis by increasing cardiac output stages of hiv infection medscape generic 5 mg medex overnight delivery, renal blood flow latent hiv infection symptoms discount medex 1 mg buy online, and the glomerular filtration rate hiv infection long term symptoms buy 1mg medex visa. The diuretic drugs described in this chapter do not increase the glomerular filtration rate hiv infection low viral load cheap 1 mg medex otc, and some of them may indirectly reduce it by decreasing plasma volume and renal blood flow hiv infection symptoms how soon medex 1 mg buy with visa. The drugs act at various sites in the nephron to cause diuresis (an increase in urine production). Most diuretics inhibit the reabsorption of sodium from the nephron into the circulation and thereby increase natriuresis (the excretion of sodium in the urine). Several types of diuretics also increase kaliuresis (the excretion of potassium in the urine) and affect the excretion of magnesium, calcium, chloride, and bicarbonate ions. Essentially all of the filtered glucose, amino acids, and other organic solutes are reabsorbed in the early portion of the proximal tubule. For reasons described later in this chapter, these drugs are relatively weak diuretics and are seldom used for this purpose, although their actions are useful in the treatment of glaucoma and other conditions. This is a relatively unimportant site of diuretic action, however, because inhibition of sodium chloride reabsorption in the proximal tubule leads to greater sodium chloride reabsorption in more distal segments of the nephron. The proximal tubule is the major site of the active tubular secretion of organic acids and bases into the nephron lumen, including both endogenous compounds. The loop diuretics and thiazide diuretics are also secreted by proximal tubular cells into the tubular lumen. Ion channels are unique membrane proteins through which a specific ion moves across the cell membrane in the direction determined by the electrochemical gradient for the ion. The transport proteins include symporters, which transport two or more ions in the same direction, and antiporters, which transport ions in opposite directions across cell membranes. Most diuretics block a specific ion channel or transporter in the tubular epithelial cells. The sites and mechanisms by 120 Loop of Henle the loop of Henle is responsible for the reabsorption of about 35% of the filtered sodium chloride. The loop also enables the urine to be concentrated by transporting sodium chloride into the surrounding interstitium where a hypertonic interstitial fluid is formed. This fluid attracts water from the adjacent collecting duct under the influence of antidiuretic hormone and thereby increases the urine concentration. The reabsorption of sodium from the thick ascending limb is inhibited by loop diuretics, which can produce a greater diuresis than any other class of diuretics. Distal Tubule the early distal tubule is responsible for the reabsorption of 5% to 10% of the filtered sodium chloride, and this reabsorption is inhibited by thiazide and related diuretics. Because of the smaller amount of sodium that is reabsorbed in the distal tubule, the diuretic effect of thiazides is less than that of the loop diuretics. Collecting Duct the collecting duct serves to adjust the final composition and volume of urine to regulate extracellular fluid composition and pH and thereby maintain physiologic homeostasis. The collecting duct is the site of action of aldosterone and antidiuretic hormone. Aldosterone is a mineralocorticoid that increases sodium reabsorption, thereby promoting sodium retention by the body. Antidiuretic hormone increases the reabsorption of water from the collecting duct, which conserves body water and concentrates the urine. The actions of these hormones are partly responsible for maintaining plasma volume and osmolality in the normal range. The collecting duct is responsible for the reabsorption of about 3% of the filtered sodium chloride. The potassium-sparing diuretics inhibit these processes and are primarily used to reduce potassium excretion and prevent hypokalemia. They are orally efficacious, have a moderate natriuretic effect, and have few adverse effects in most patients. Thiazides are sulfonamide compounds and were the first orally administered diuretics to be widely used for the treatment of hypertension and edema. Thiazides exhibit good oral bioavailability and are actively secreted into the nephron by proximal tubular cells, and they travel through the nephron lumen to reach their site of action in the distal tubule. Some of the thiazides are partially metabolized before excretion in the urine (Table 13-2). Thiazide diuretics act on the early portion of the distal tubule to inhibit the Na+,Cl- symporter that participates in the reabsorption of sodium and chloride from this segment of the nephron (see Box 13-1). This action leads to the delivery of a greater volume of sodium chloride­enriched tubular fluid to the late distal tubule and collecting duct, which in turn stimulates the exchange of sodium and potassium at these sites. In the process, a small amount of sodium is reabsorbed as potassium is secreted into urine in the tubules. By this mechanism, thiazides have a kaliuretic effect that leads to hypokalemia in some patients. As shown in Table 13-3, thiazides increase magnesium excretion, but (unlike many diuretics) they decrease calcium excretion in the urine. The reduced calcium excretion appears to result from decreased expression of calcium transport proteins, including the epithelial calcium channel, calbindin, and the sodium-calcium exchanger protein, in renal tubules after thiazide administration. The ability of thiazides to reduce calcium excretion is the basis for their use in the treatment of kidney stones caused by excessive calcium in the urine. Table 13-4 lists the common adverse effects and interactions of thiazides and other diuretics. Thiazide diuretics sometimes cause hypokalemia, particularly in patients whose dietary potassium intake is inadequate. In this disorder, hydrogen ions enter body cells as potassium leaves these cells in an attempt to correct the plasma potassium deficiency. In the distal tubule (C), sodium is transported into tubular epithelial cells by the Na+,Cl- symporter and then is transferred to interstitial fluid by the sodium pump. The potassium-sparing diuretics exert their effects via two mechanisms: amiloride and triamterene inhibit the entrance of sodium into the principal cells, whereas spironolactone blocks the mineralocorticoid receptor and thereby inhibits sodium reabsorption and potassiumsecretion. In cases of hypokalemic metabolic alkalosis, potassium chloride is administered intravenously and orally. Correction of the serum potassium level then leads to correction of the acid-base disturbance as potassium displaces hydrogen ions from body cells and fewer hydrogen ions are secreted by the collecting duct. In addition to causing electrolyte and acid-base disturbances, the thiazides can cause several metabolic abnormalities, including elevated blood glucose, uric acid, and lipid levels. Thiazides appear to decrease insulin sensitivity and thereby contribute to the development of diabetes in some patients. Hyperuricemia, which is caused by inhibition of uric acid secretion from the proximal tubule, can lead to the development of gout. The effects of thiazide diuretics on serum lipid levels are discussed in greater detail in Chapter 10. Thiazide diuretics are widely used in the management of cardiovascular and renal diseases (see Table 13-1). They are often prescribed for hypertension and can be used to treat edema associated with heart failure, cirrhosis, corticosteroid therapy, estrogen therapy and renal disorders such as nephrotic syndrome. Because thiazides reduce calcium excretion and decrease urinary calcium levels, they are helpful in treating patients with nephrolithiasis (kidney stones) associated with hypercalciuria. In this disorder, the kidneys are not responsive to circulating antidiuretic hormone, and patients may excrete from 10 to 20 L of urine per day. Thiazides exert a paradoxical antidiuretic effect in these patients and reduce the excessive urine volume dramatically. In cases of diabetes insipidus, the effectiveness of thiazides is believed to stem from a reduction in plasma volume caused by these drugs. The reduced plasma volume serves to increase sodium and water reabsorption from the proximal tubule, so that less water is delivered to the diluting segments of the nephron. A, Inhibition of uric acid secretion in the proximal tubule can lead to hyperuricemia and gout. Hypokalemia can lead to metabolic alkalosis by promoting the exchange of intracellular potassium for hydrogen ions and by increasing the excretion of hydrogen ions. The increased excretion is caused by lack of availability of potassium for exchange with sodium in the collecting duct. B, In the presence of hypokalemia, the amount of insulin secreted by the pancreas can be reduced, thereby leading to hyperglycemia. Hydrochlorothiazide the several thiazide compounds that are available have almost identical actions but differ in their potency and pharmacokinetic properties. Thiazide-like Diuretics Thiazide-like diuretics have a different chemical structure, but their actions and uses are similar to those of the thiazides. Indapamide has both diuretic and vasodilator actions and is indicated for the treatment of hypertension and heart failure. They are the preferred diuretics in the treatment of persons with renal impairment, because (unlike thiazide and other diuretics) they are effective in patients whose creatinine clearance drops below 30 mL/min. Loop diuretics are often the drugs of choice for patients with edema caused by heart failure, cirrhosis, and other disorders. Although they are prescribed for patients with hypertension, the thiazide diuretics are usually preferred for this condition. Loop diuretics can be used to treat hypercalcemia, whereas the thiazide diuretics can increase serum calcium levels slightly. Bumetanide, Furosemide, and Torsemide Bumetanide, furosemide, and torsemide are sulfonamide derivatives with similar pharmacologic actions and effects. In comparison with other loop diuretics, torsemide has a somewhat longer half-life and a significantly longer duration of action after intravenous administration (see Table 13-2). All three of the drugs are partly metabolized before they are excreted in the urine. Ethacrynic Acid Ethacrynic acid is the only loop diuretic that is not a sulfonamide derivative, and it is occasionally used when patients are allergic or intolerant to the sulfonamide drugs in this class. Otherwise, it is seldom used because it tends to produce more ototoxicity than do other loop diuretics. Loop diuretics produce dose-dependent diuresis throughout their therapeutic dosage range, whereas thiazide diuretics have a relatively flat dose-response curve and a limited maximal response. Loop diuretics inhibit the Na+,K+,2Cl- symporter in the ascending limb of the loop of Henle and thereby exert a powerful natriuretic effect. In comparison with other diuretics, loop diuretics can inhibit the reabsorption of a greater percentage of filtered sodium. Loop diuretics are sometimes called high-ceiling diuretics because they produce a dose-dependent diuresis throughout their clinical dosage range. This property can be contrasted with the rather flat dose-response curve and limited diuretic capability of thiazides and other diuretic drugs. In addition to their natriuretic effect, the loop diuretics produce kaliuresis by increasing the exchange of sodium and potassium in the late distal tubule and collecting duct via the same mechanisms as those described for the thiazide diuretics. Loop diuretics also increase magnesium and calcium excretion by reducing the reabsorption of these ions in the ascending limb (see Box 13-1). This action results from inhibition of the Na+,K+,2Cl- symporter, which reduces the back-diffusion of potassium into the nephron lumen. The reduction of potassium back-diffusion decreases the transepithelial electrical potential that normally drives the paracellular reabsorption of magnesium and calcium. Loop diuretics can produce a variety of electrolyte abnormalities, including hypokalemia, hypocalcemia, hypomagnesemia, and metabolic alkalosis. These diuretics can also increase blood glucose and uric acid levels in the same manner as the thiazide diuretics. In some patients, use of loop diuretics causes ototoxicity with manifestations such as tinnitus, ear pain, vertigo, and hearing deficits. Loop diuretics are used when intensive diuresis is required and cannot be achieved with other diuretics. Loop diuretics are highly effective in the treatment of pulmonary edema, partly because of the vasodilation that Potassium-Sparing Diuretics Two types of potassium-sparing diuretics exist: the epithelial sodium channel blockers and the aldosterone receptor antagonists. Amiloride and Triamterene Amiloride and triamterene are epithelial sodium channel blockers. By blocking the entry of sodium into the principal tubular cells of the late distal tubule and collecting duct (see Box 13-1), these drugs prevent sodium reabsorption at this site and indirectly reduce the secretion of potassium into the tubular filtrate and urine. Through these actions, the potassium-sparing diuretics produce a modest amount of natriuresis but decrease kaliuresis. Amiloride and triamterene are primarily used to prevent and treat hypokalemia induced by thiazide and loop diuretics. The properties, effects, and uses of amiloride, triamterene, and other potassium-sparing diuretics are outlined in Tables 13-1 to 13-4. The most characteristic adverse effect of the potassiumsparing diuretics is hyperkalemia, but this is unlikely to occur unless the patient also ingests potassium supplements or other drugs that increase serum potassium levels. Spironolactone Spironolactone is a structural analog of aldosterone that competitively blocks aldosterone binding to the mineralocorticoid receptor in epithelial cells of the late distal tubule and collecting duct. By blocking these actions, spironolactone reduces sodium reabsorption and the accompanying secretion of potassium. Spironolactone is adequately absorbed from the gut and has a long duration of action despite its short elimination half-life, indicating that its cellular actions persist longer than do circulating drug levels (see Table 13-2). Spironolactone is used to prevent hypokalemia in the same manner as amiloride and triamterene, and it has a special role in the treatment of primary hyperaldosteronism. Clinical trials have shown that spironolactone reduces mortality in persons with heart failure, as described in Chapter 12. Its use in this condition, however, has been associated with an increased incidence of hyperkalemia. Because of its antiandrogenic effect, spironolactone is also used in the treatment of polycystic ovary disease and hirsutism in women.

Syndromes

• Avoid fluoride mouth rinses in children younger than 6 years.
• Reactions to medicines
• Trisomy 18
• Have others avoid contact with the baby if they have a cold or fever. If necessary, have them wear a mask.
• Norgestrel and ethinyl estradiol (Lo Ovral, Ovral)
• You have any other unusual symptoms
• Culture of cells from the esophagus for herpes or CMV
• Atrial fibrillation
• Properly naming the primary colors and possibly many more

In patients with renal impairment hiv infection rates worldwide 1 mg medex buy overnight delivery, as indicated by reduced creatinine clearance hiv infection unprotected penetration purchase 5mg medex mastercard, dosage should be decreased stages of hiv infection wiki medex 5 mg buy with amex. Aztreonam Chemistry Aztreonam [Azactam hiv infection rate hong kong buy medex visa, Cayston] belongs to a class of beta-lactam antibiotics knownasmonobactams four early symptoms hiv infection cheap 1mg medex otc. Therefore,likemostbeta-lactamantibiotics,thedrug inhibits bacterial cell wall synthesis and thereby promotes cell lysis and death. Aztreonam is highly resistant to betalactamases and therefore is active against many gram-negative aerobes that produce them. Because aztreonam differs greatly in structure from penicillins and cephalosporins, there is little cross-allergenicity with them. Hence aztreonam appears safe for patients with allergies to other beta-lactam antibiotics. Inhalational Aztreonam, sold as Cayston, should be inhaled using the Altera Nebulizer System. Fosfomycin may also cause abdominal pain, rhinitis, drowsiness, dizziness,andrash. Ingeneral,thedrugspresented here are second-line agents, used primarily for infections resistant to first-line agents. All four-tetracycline, demeclocycline, doxycycline, and minocycline-are similar in structure, antimicrobialactions,andadverseeffects. MechanismofAction the tetracyclines suppress bacterial growth by inhibiting protein synthesis. Selective toxicity of the tetracyclines results from their poor ability to cross mammalian cell membranes. To influence protein synthesis, tetracyclines must first gain access to the cell interior. TherapeuticUses TreatmentofInfectiousDiseases Extensive use of tetracyclines has resulted in increasing bacterial resistance. Because of resistance, and because antibiotics with greater selectivity and less toxicityarenowavailable,useoftetracyclineshasdeclined. TreatmentofAcne Tetracyclines are used topically and orally for severe acne vulgaris. Beneficial effects derive from suppressing the growth and metabolic activity of Propionibacterium acnes, an organism that secretes inflammatory chemicals. PeriodontalDisease Two tetracyclines-doxycycline and minocycline-are used for periodontal disease. Pharmacokinetics Individual tetracyclines differ significantly in their pharmacokinetic properties. DurationofAction the tetracyclines can be divided into three groups: short acting, intermediate acting, and long acting. These differences are related to differences in lipid solubility: the only short-acting agent (tetracycline) has relatively low lipid solubility, whereas the long-acting agents (doxycycline, minocycline) have relativelyhighlipidsolubility. Absorption All of the tetracyclines are orally effective, although the extent of absorption differs among individual agents. Absorption of three agents-tetracycline, demeclocycline, and doxycycline-is reduced by food, whereas absorption of minocyclineisnot. The tetracyclines form insoluble chelates with calcium, iron, magnesium, aluminum,andzinc. Distribution Tetracyclines are widely distributed to most tissues and body fluids. Ultimate elimination of short- and intermediate-acting tetracyclines- tetracyclineanddemeclocycline-isintheurine,largelyastheunchangeddrug. Because these agents undergo renal elimination, they can accumulate to toxic levelsifthekidneysfail. Accordingly, the long-acting agents (doxycycline and minocycline) are drugs of choice for tetracycline-responsive infections in patientswithrenalimpairment. As a result, oral therapy is frequently associated with epigastric burning, cramps, nausea, vomiting, and diarrhea. These reactions can be reduced by giving tetracyclines with meals- although food may decrease absorption. The intensity of tooth discoloration is related to the total cumulative dose: staining is darker with prolonged and repeated treatment. When taken after the fourth month of gestation, tetracyclines can cause staining of deciduous teeth of the infant. Superinfection A superinfection is an overgrowth with drug-resistant microbes, which occurs secondarytosuppressionofdrug-sensitiveorganisms. Patients should notify the prescriber if significant diarrhea occurs so that the possibility of bacterial superinfection can be evaluated. Overgrowth with fungi (commonly Candida albicans) may occur in the mouth,pharynx,vagina,andbowel. Liver damage is most likely when tetracyclines are administered intravenously in high doses (greater than 2g/day). RenalToxicity Tetracyclines may exacerbate renal impairment in patients with preexisting kidney disease. Advise patients to avoid prolonged exposure to sunlight, wear protective clothing, and apply a sunscreentoexposedskin. Rarely, tetracyclines have produced pseudotumor cerebri (a benign elevation in intracranial pressure). In a few patients, demeclocycline has produced nephrogenic diabetes insipidus, a syndromecharacterizedbythirst,increasedfrequencyofurination,andunusual weakness or tiredness. If a tetracycline is administered with these agents, its absorption will be decreased. Oral administration is preferred, and all tetracyclines are available in oral formulations. Aninterval of at least 2 hours should separate tetracycline ingestion and ingestion of products that can chelate these drugs. MajorPrecautions Two tetracyclines-tetracycline and demeclocycline-are eliminated primarily in the urine and hence will accumulate to toxic levels in patients with kidney disease. When employed systemically, the drug has the indications, pharmacokinetics, adverse effects, and drug interactions described for the tetracyclines as a group. Like most tetracyclines, tetracycline hydrochloride should not be administered with food and is contraindicated for patients with renalimpairment. Demeclocycline Demeclocycline [Declomycin] shares the actions, indications, and adverse effects described previously for the tetracyclines as a group. Because of its intermediate duration of action, demeclocycline can be administered at dosing intervals that are longer than those used for tetracycline. Demeclocycline is unique among the tetracyclines in that it stimulates urine flow. Because of its extended half-life, doxycycline can be administered once daily in some situations. Doxycycline is a first-line drug for Lyme disease, anthrax, chlamydial infections(urethritis,cervicitis,andlymphogranulomavenereum),andsexually acquired proctitis (in combination with ceftriaxone). A topical formulation [Atridox] is used for periodontal disease, as is a low-dose oral formulation [Periostat]. Minocycline Minocycline [Minocin, others] is a long-acting agent similar to doxycycline. Macrolides the macrolides are broad-spectrum antibiotics that inhibit bacterial protein synthesis. Thedrug is active against most gram-positive bacteria as well as some gram-negative bacteria. Erythromycin is considered the drug of first choice for individuals infected with Bordetella pertussis, the causative agent of whooping cough. Both are drugs of first choice for certain chlamydial infections (urethritis, cervicitis) andforpneumoniacausedbyM. Pharmacokinetics AbsorptionandBioavailability Erythromycin for oral administration is available in three forms: erythromycin base and two derivatives of the base: erythromycin stearate and erythromycin ethylsuccinate. Thebaseisunstablein stomach acid,anditsabsorptioncanbe variable; the derivatives were synthesized to improve bioavailability. Asa rule, food decreases the absorption of erythromycin base and erythromycin stearate, whereas absorption of erythromycin ethylsuccinate is not affected. However, this should be done only when using erythromycin products whose absorption is unaffected by food (erythromycin ethylsuccinate, certain enteric-coated formulations of erythromycin base). DrugInteractions Erythromycin can increase the plasma levels and half-lives of several drugs, thereby posing a risk for toxicity. Elevated levels are a concern with theophylline (used for asthma), carbamazepine (used for seizures and bipolar disorder), and warfarin (an anticoagulant). Erythromycin prevents binding of chloramphenicol and clindamycin to bacterial ribosomes, thereby antagonizing their antibacterial effects. Accordingly, concurrent use of erythromycin with these two drugs is not recommended. As noted, erythromycin should not be combined with drugs that can inhibit erythromycinmetabolism. After absorption, clarithromycin is widely distributed and readily penetrates cells. AdverseEffectsandInteractions Clarithromycin is well tolerated and does not produce the intense nausea seen with erythromycin. The most common reactions (3%) have been diarrhea, nausea,anddistortedtaste-alldescribedasmildtomoderate. Inclinicaltrials, only 3% of patients withdrew because of side effects, compared with 20% of those taking erythromycin. High doses of clarithromycin have caused fetal abnormalities in laboratory animals; possible effects on the human fetus are unknown. Like erythromycin, clarithromycin can inhibit hepatic metabolism of other drugs and can thereby elevate their levels. Thedrugisusedfor respiratory tract infections, cholera, chancroid, otitis media, uncomplicated infections of the skin and skin structures, disseminated M. After absorption, azithromycin is widely distributed to tissues and becomes concentrated in cells. AdverseEffectsandInteractions Like clarithromycin, azithromycin is well tolerated and does not produce the intense nausea seen with erythromycin. Aluminum- and magnesium-containing antacids reduce the rate (but not the extent) of absorption. Susceptible anaerobes include Bacteroides fragilis, Fusobacterium species, Clostridium perfringens, and anaerobic streptococci. The drug is widely distributed to most body fluids and tissues, including synovial fluid and bone. In patients with substantial reductions in liver function or kidney function, the half-life increases slightly, but adjustments in dosage are not needed. Hepatotoxicity and blood dyscrasias (agranulocytosis, leukopenia, thrombocytopenia) develop rarely. Clindamycinpalmitate[CleocinPediatric]issuppliedin flavored granules, which are reconstituted with fluid to make an oral solution containing 15mg of clindamycin per milliliter. For clindamycin palmitate, adult and pediatric dosages range from 8 to 25mg/kg/day administered in three or four divided doses. IntravaginalAdministration Intravaginal clindamycin (suppositories or cream) is indicated for bacterial vaginosis. The suppositories are approved only for nonpregnant women; the cream can be used by pregnant women, but only during the second and third trimesters. Women using clindamycin cream should insert 1 applicatorful (5g containing 100mg clindamycin) nightly for 7 days (if pregnant) or for 3 to 7 days (if nonpregnant). Women using clindamycin suppositories should insert 1 suppository(100mg)onthreeconsecutiveevenings. Thedrugbindstothe 23S portion of the 50S ribosomal subunit and thereby blocks formation of the initiationcomplex. Linezolid is active primarily against aerobic and facultative gram-positive bacteria. Susceptible pathogens include Enterococcus faecium (vancomycinsensitive and vancomycin-resistant strains), Enterococcus fecalis (vancomycinresistant strains), S. Linezolid can cause reversible myelosuppression, manifesting as anemia, leukopenia,thrombocytopenia,orevenpancytopenia. Pharmacokinetics Peak plasma concentrations of oral tedizolid are reached within 3 hours of administration. AdverseEffects the most common side effects associated with tedizolid are diarrhea, nausea, vomiting, dizziness, and headache. Preparations,Dosage,andAdministration Tedizolid is available in two formulations: 200-mg tablets and an intravenous solution. Unfortunately, although telithromycin is an effective antibiotic, it carries a significant risk for adverse effects (especially severe liver injury) and drug interactions. As a result, it should be reserved for infections caused by multidrug-resistant S. MechanismofAction Like the macrolides, telithromycin binds to the 50S ribosomal subunit and thereby inhibits bacterial protein synthesis. Pharmacokinetics Telithromycin undergoes rapid but incomplete absorption after oral administration. AdverseEffects Although telithromycin is generally well tolerated, the drug can cause serious adverse effects, especially injury to the liver (see later). The most common adverse effects are gastrointestinal disturbances,includingdiarrhea,nausea,vomiting,andloosestools.

Buy medex on line. Yoga for HIV/AIDS - Rebuild Your Immune System | Easy Yoga Therapy.

References

• Chuck AJ, Patrick MG, Hamilton E, et al. Crystal deposition in hypophosphatasia: A reappraisal. Ann Rheum Dis 1989;48:571.
• Viscoli C, Girmenia C, Marinus A, et al. Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis. 1999;28:1071-1079.
• Derdeyn CP, Grubb RLJr, Powers WJ. Cerebral hemodynamic impairment: Methods of measurement and association with stroke risk. Neurology 1999;53:251-9.
• Yu Y, Fuhr J, Boye E, et al: Mesenchymal stem cells and adipogenesis in hemangioma involution, Stem Cells 24(6):1605-1612, 2006.
• Trockman BA, Gerspach J, Dmochowski R, et al: Primary bladder neck obstruction: urodynamic findings and treatment results in 36 men, J Urol 156(4):1418n1420, 1996.
• Khafaga Y, Hassounah M, Kandil A, et al. Optic gliomas: a retrospective analysis of 50 cases. Int J Radiat Oncol Biol Phys 2003;56(3):807-812.